Urinary Bladder, Neurogenic
29
4
6
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.9%
2 terminated out of 29 trials
88.2%
+1.7% vs benchmark
24%
7 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (29)
Recovery of Bladder and Sexual Function After Human Spinal Cord Injury
Heart Rate Variability and Anxiety During Urinary Bladder Catheterization
A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections
Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
Pediatric Urology Recovery After Surgery Endeavor (PURSUE)
Measurement of Bladder Pressure With a Novel External Device (Cystomanometer) - Home Use
Cystoealstometer (Bladder Monitor Device)-Home Use
Effect of Urethral Balloon Dilatation on Urinary Retention After Spinal Cord Injury
NXT Post-Market Clinical Follow-up
Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing
Ambulatory Closed-loop Stimulation for Bladder Control
Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple Sclerosis
Cystometry Using a Novel Microsensor System in Patients With Neurogenic Bladder Dysfunction
Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple Sclerosis
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition
Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.
Transcutaneous Peripheral Neuromodulation for Neurogenic Bladder
Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury
Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients